R. Douglas Armstrong, Ph.D - Senior Managing Director

R. Douglas Armstrong, Ph.D., has over 25 years of life science industry business and finance experience, with emphasis on early stage and emerging growth companies.

Dr. Armstrong is a seasoned and diverse life science operational and banking executive, including serving as the CEO of TyraTech and Aastrom Biosciences (where he has also Chairman), leading both through initial public development and implementation of capital strategies having personally led over $300 M capital raises PIPE and other structured deals, including strategic partnering transactions with capital investment. Dr. Armstrong has also served at the chairman or board level of multiple public and private companies, including the advisory board of a venture capital fund. He is a founding partner of Auxol Capital life science investments, and was most recently a member of the senior management team for LifeTech Capital. Dr. Armstrong holds a Ph.D. degree in Pharmacology from the Medical College of Virginia, and a BA degree in Chemistry from the University of Richmond